Skip to main content

New story in Health from Time: The World Records Its 20 Millionth Case of COVID-19



There are a lot of ways to try to capture grim milestone the world crossed Monday night when it recorded its 20 millionth case of COVID-19. It’s two Swedens, four Irelands, 10 Slovenias. It’s greater than the entire population of the state of New York. The outbreak that began in Wuhan, China in December 2019 has now spread to 188 countries and regions, touching every continent but Antarctica.

The U.S. continues to lead the world in total cases, having crossed its own milestone—to 5 million—on August 9. Brazil comes next, with 3 million; followed by India at 2.2 million; Russia at 890,000; and South Africa, at 560,000. Global death tolls have now surpassed 732,000, led again by the U.S., at over 163,000.

Among the top 20 countries—a list which also includes Mexico, Peru, Spain, the United Kingdom and Pakistan—there are some small but encouraging signs. Five-day moving averages are trending down in 11 of those hard-hit spots, with the U.S. among those showing some faint improvement. But the remaining nine have all seen cases rise over the same period.

As with all pandemics, the increase in caseload has not remotely been linear, and instead is accelerating rapidly. It took from December until April 2 before one million cases were recorded worldwide. The number then took less than seven weeks to quintuple to 5 million cases, on May 20. The 10 million milestone was reached just over five weeks later, on June 28. On August 6, the world hit 19 million cases—and now it’s 20 million. Looked at another way, it took nearly four months for first million people to be diagnosed, but just 4 days to record the most recent million.

Slowing that trend depends on all of those 188 countries and regions doing their part to control their infection rate, but the majority of the responsibility lies with the big five countries to flatten their domestic curves. Within the U.S., the burden falls especially on the big three states—Texas, California and Florida, which together represent more than 40% of new domestic cases over the past 14 days—to put their coronavirus genie back in the bottle. At the current global rate, the 21 million mark will be reached before the weekend.

Popular posts from this blog

New story in Health from Time: COVID-19 Has Been ‘Apocalyptic’ for Public Transit. Will Congress Offer More Help?

While trying to get to work over the past few months, Brittany Williams, a Seattle home care worker, has often been passed by two or three buses before one stops to let her board. Buses in her area that once carried anywhere from about 50 to 100 passengers have been limited to between 12 and 18 to prevent overcrowding in response to coronavirus, and Williams’ commute, typically a half-hour ride, now takes more than double that time. Other Seattle transit riders have described budgeting as much as an extra hour per trip to account for the reduced capacity, eating into their time at work, school or with family. Even with the ridership limits in place, Williams, 34, doesn’t feel safe on public transit. Some passengers don’t wear face coverings, and bus drivers sometimes ignore capacity limits, she says. On one ride with her seven-year-old son, she decided to get off at a stop far from her home after a driver allowed a crowd of people to board. “It’s very trying. I’ll put...

New story in Health from Time: An At-Home Coronavirus Test May Be On the Way in the U.S.

As cases of COVID-19 continue to climb in the U.S. , there’s a new urgency to make sure there are as many tests as possible to diagnose people who have symptoms that might indicate an infection. Knowing if people are positive is important for guiding their next steps: self-isolation, avoiding contact with others, and, if their symptoms get worse, seeking medical care. To date, access to tests has been spotty at best across the country, and while more kits are now available than even a week ago , most are gene-based assays that take several days for commercial labs to process and produce results. That may change in about two months if the Food and Drug Administration (FDA) gives Emergency Use Authorization to the first blood-based COVID-19 test in the U.S. Scanwell Health, an at-home test company based in California, licensed the rights to a test developed by Chinese company Innovita, which was used extensively at the height of country’s epidemic earlier this year. “The ...

New story in Health from Time: AFM, a Biennial Polio-Like Viral Illness, Is Expected to Hit the U.S. in 2020

Nobody foresaw the COVID-19 curveball nature was going to throw at us 2020—which is one of the reasons the world has had so much trouble ducking the pitch. But we’ve know for years that another disease, known as acute flaccid myelitis (AFM), would hit hard this year—beginning this month, in fact. The U.S. Centers for Disease Control and Prevention (CDC) today held a media teleconference and issued a Vital Signs report reminding families that the illness is fast-approaching, and that in a time of pandemic there could be particular challenges in responding to it that would not be present in other years. AFM is a paralytic condition that is not polio—but not dissimilar to polio either. It strikes mostly children (the average age is 5); it is caused by a virus (likely an enterovirus, a type that incubates in the gut); and worst of all, it can lead to paralysis of the limbs, face and diaphragm, sometimes resulting in death. Like polio, AFM is seasonal, though its peak is Augus...